Duration of untreated illness as a predictor of treatment response and clinical course in generalized anxiety disorder
- PMID: 18496479
- DOI: 10.1017/s1092852900016588
Duration of untreated illness as a predictor of treatment response and clinical course in generalized anxiety disorder
Abstract
Introduction: The aim of the present study was to investigate the impact of the duration of untreated illness (DUI)-defined as the time elapsing between the onset of generalized anxiety disorder (GAD) and the first adequate pharmacologic treatment-on treatment response and clinical course in a sample of subjects with GAD.
Methods: One hundred patients with GAD, diagnosed according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition-Text Revision criteria, were enrolled and their main demographic and clinical features collected. Patients were then treated with selective serotonin reuptake inhibitors or venlafaxine for 8 weeks in open-label conditions. Treatment response and other clinical variables were analyzed after dividing the sample into two groups according to DUI (DUI <or=12 months and DUI >12 months).
Results: When the DUI was computed with respect to the first antidepressant treatment (DUI-AD), a higher improvement (Clinical Global Impressions-Severity of Illness scale) after the pharmacologic treatment was found in the group with a shorter DUI (analysis of variance with repeated measures: time effect F=654.975, P<.001; group effect: F=4.369, P=.039). When computed with respect to the first treatment with benzodiazepines (DUI-BDZ), the two groups did not show any significant difference in treatment response (time effect: F=652.183, P<.001; group effect: F=0.009, P=.924). In addition, patients with a longer DUI (DUI-BDZ or DUI-AD) showed an earlier age at onset, a longer duration of illness and a higher rate of comorbid psychiatric disorders with onset later than GAD.
Conclusion: Results from this preliminary study seem to suggest that a shorter DUI-AD may determine a better response to pharmacologic treatment in patients with GAD, and that a longer DUI (DUI-BDZ and DUI-AD) may be associated to a worse clinical course. Further investigation on the relationship between DUI and GAD is needed.
Similar articles
-
Duration of untreated illness in major depressive disorder: a naturalistic study.Int J Clin Pract. 2007 Oct;61(10):1697-700. doi: 10.1111/j.1742-1241.2007.01450.x. Int J Clin Pract. 2007. PMID: 17877655
-
Latency to selective serotonin reuptake inhibitor vs benzodiazepine treatment in patients with panic disorder: a naturalistic study.CNS Spectr. 2023 Feb;28(1):46-52. doi: 10.1017/S1092852921000869. Epub 2021 Nov 5. CNS Spectr. 2023. PMID: 34736545
-
Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.JAMA. 2000 Jun 21;283(23):3082-8. doi: 10.1001/jama.283.23.3082. JAMA. 2000. PMID: 10865302 Clinical Trial.
-
Duration of untreated illness and duration of illness in anxiety disorders: assessment and influence on outcome.Mod Trends Pharmacopsychiatry. 2013;29:111-8. doi: 10.1159/000351950. Epub 2013 Sep 20. Mod Trends Pharmacopsychiatry. 2013. PMID: 25225021 Review.
-
Generalized anxiety disorder in primary care: emerging issues in management and treatment.J Clin Psychiatry. 2002;63 Suppl 8:35-42. J Clin Psychiatry. 2002. PMID: 12044106 Review.
Cited by
-
Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs.Prim Care Companion J Clin Psychiatry. 2010;12(2):PCC.09r00772. doi: 10.4088/PCC.09r00772blu. Prim Care Companion J Clin Psychiatry. 2010. PMID: 20694114 Free PMC article.
-
Barriers and facilitators for treatment-seeking in adults with a depressive or anxiety disorder in a Western-European health care setting: a qualitative study.BMC Psychiatry. 2022 Mar 5;22(1):165. doi: 10.1186/s12888-022-03806-5. BMC Psychiatry. 2022. PMID: 35247997 Free PMC article.
-
Digital Interventions for People Waitlisted for Mental Health Services: A Needs Assessment and Preference Survey.Pract Innov (Wash D C). 2025 Mar;10(1):32-42. doi: 10.1037/pri0000250. Epub 2024 Jul 29. Pract Innov (Wash D C). 2025. PMID: 40256356
-
Factors associated with anxiety disorder comorbidity.J Affect Disord. 2023 Feb 15;323:280-291. doi: 10.1016/j.jad.2022.11.051. Epub 2022 Nov 26. J Affect Disord. 2023. PMID: 36442657 Free PMC article.
-
Association between recognition and help-seeking preferences and stigma towards people with mental illness.Epidemiol Psychiatr Sci. 2018 Feb;27(1):84-93. doi: 10.1017/S2045796016000998. Epub 2016 Dec 8. Epidemiol Psychiatr Sci. 2018. PMID: 27927259 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical